Sreechem Resins

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE377C01010
  • NSEID:
  • BSEID: 514248
INR
32.55
-1.5 (-4.41%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 1.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.4 k (337.50%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.05%

Held by 0 DIIs

Promoter

24.80%

Why is Sreechem Resins Ltd. falling/rising?

15-Jun-2026

As of 14-Jun, Sreechem Resins Ltd. is facing a significant decline in its stock price, currently at Rs 34.05, down 4.89%, and underperforming against the Sensex. Weak long-term fundamentals, negative operating profits, and a bearish trend indicated by trading below moving averages contribute to the stock's downward trajectory.

As of 14-Jun, Sreechem Resins Ltd. is experiencing a decline in its stock price, currently at Rs 34.05, which reflects a change of -1.75 (-4.89%). This drop is part of a broader trend, as the stock has underperformed significantly compared to the benchmark Sensex, showing a 1-week decline of -4.89% while the Sensex gained +1.73%. Over the past month, the stock has decreased by -6.07%, again contrasting with the Sensex's modest gain of +1.30%.<BR><BR>Today's trading performance indicates that the stock opened with a loss of -4.89% and has not fluctuated beyond this price point, suggesting a lack of investor confidence. Furthermore, Sreechem Resins is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend.<BR><BR>Despite some positive financial results reported on March 26, such as the highest PBDIT and operating profit margins, the company's long-term fundamentals appear weak. The company has recorded a negative EBIT of Rs -0.38 crore and a concerning -167.51% CAGR growth in operating profits over the last five years. This weak financial position, combined with a poor EBIT to interest ratio of 1.84, raises concerns about the company's ability to service its debt, further contributing to the stock's decline.<BR><BR>Additionally, while there has been a notable increase in delivery volume, rising by 400% against the 5-day average, this does not seem to have translated into positive price movement. Overall, the combination of poor long-term fundamentals, negative operating profits, and underperformance relative to the market is driving the stock price of Sreechem Resins Ltd. lower.

View full answer

What does Sreechem Resins do?

11-Jun-2026

Sreechem Resins Ltd. is a manufacturer of commodity chemicals, primarily focusing on resin production. As of March 2026, it reported net sales of 8 Cr and a net profit of 1 Cr, with a market cap of INR 14 Cr.

Overview: <BR>Sreechem Resins Ltd. is a leading manufacturer in the commodity chemicals industry, specializing in the production of various types of resins.<BR><BR>History: <BR>Sreechem Resins Limited was incorporated on May 16, 1988. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 8 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 1 Cr (Quarterly Results - Mar 2026) <BR>Market-cap: INR 14 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.15 <BR>Return on Equity: -1.40% <BR>Price to Book: 1.00<BR><BR>Contact Details: <BR>Address: Vill Jhagarpur, P B No 13 Post Rajgangpur Sundargarh Orissa : 770017 <BR>Tel: 91-06624-211943/211944/211943 <BR>Email: sreechem@sreechem.in <BR>Website: http://www.sreechem.com

View full answer

How big is Sreechem Resins?

11-Jun-2026

As of 10th June, Sreechem Resins Ltd. has a market capitalization of 14.00 Cr and reported net sales of 29.75 Cr with a net loss of 0.20 Cr over the latest four quarters. Shareholder's funds are 14.29 Cr, and total assets amount to 17.27 Cr as of March 2025.

As of 10th June, Sreechem Resins Ltd. has a market capitalization of 14.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Sreechem Resins reported net sales of 29.75 Cr. However, the net profit for the same period showed a loss of 0.20 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025. Shareholder's funds are reported at 14.29 Cr, while total assets amount to 17.27 Cr.

View full answer

Who are in the management team of Sreechem Resins?

11-Jun-2026

The management team of Sreechem Resins includes Binod Sharma (Executive Director & Managing Director), Vikram Kabra and Vibhor Sharma (Executive Directors & Wholetime Directors), along with independent directors Sweta Maheshwari, Niwesh Sharma, and Vinay Joshi, and Komal Bhauwala as Company Secretary & Compliance Officer.

The management team of Sreechem Resins includes the following individuals:<BR><BR>1. **Binod Sharma** - Executive Director & Managing Director<BR>2. **Vikram Kabra** - Executive Director & Wholetime Director<BR>3. **Vibhor Sharma** - Executive Director & Wholetime Director<BR>4. **Sweta Maheshwari** - Independent Non-Executive Director<BR>5. **Niwesh Sharma** - Independent Non-Executive Director<BR>6. **Vinay Joshi** - Independent Non-Executive Director<BR>7. **Komal Bhauwala** - Company Secretary & Compliance Officer<BR><BR>If you need more information about any specific member or their roles, feel free to ask!

View full answer

Who are the peers of the Sreechem Resins?

11-Jun-2026

Sreechem Resins' peers include Tulasee Bio-Eth., Square Four Pro., Jayshree Chem., and others. Sreechem has below-average growth and management risk, with a 1-year return of -10.50%, while Kobo Biotech leads with a 134.11% return.

Peers: The peers of Sreechem Resins are Tulasee Bio-Eth., Square Four Pro., Jayshree Chem., Vivid Global, Omkar Pharmachem, Kobo Biotech, Emmessar Biotech, Kuwer Industries, Link Pharma Chem, and Lime Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sreechem Resins, while Average management risk is found at Emmessar Biotech. Below Average management risk is noted for Jayshree Chem., Vivid Global, Kuwer Industries, and Link Pharma Chem, and the rest do not qualify. Growth is Average at Jayshree Chem., while Below Average growth is seen at Sreechem Resins, Emmessar Biotech, Vivid Global, Kuwer Industries, and the rest do not qualify. Capital Structure is Good at Vivid Global, while Below Average is noted for Sreechem Resins, Emmessar Biotech, Jayshree Chem., Kuwer Industries, Link Pharma Chem, and the rest do not qualify.<BR><BR>Return Snapshot: Kobo Biotech has the highest 1-year return at 134.11%, while Omkar Pharmachem has the lowest at -28.97%. Sreechem Resins' 1-year return is -10.50%, which is higher than Omkar Pharmachem's but lower than Kobo Biotech's. Additionally, Omkar Pharmachem, Emmessar Biotech, and Link Pharma Chem have negative six-month returns.

View full answer

Should I buy, sell or hold Sreechem Resins Ltd.?

30-May-2026

When is the next results date for Sreechem Resins Ltd.?

21-May-2026

The next results date for Sreechem Resins Ltd. is 29 May 2026.

The next results date for Sreechem Resins Ltd. is scheduled for 29 May 2026.

View full answer

Are Sreechem Resins Ltd. latest results good or bad?

06-Feb-2026

Sreechem Resins Ltd.'s latest results are concerning, showing a 29.69% year-on-year decline in net sales and continued operating losses, with a net loss of ₹0.55 crores. The company faces significant operational challenges and negative return metrics, indicating a difficult financial position.

Sreechem Resins Ltd.'s latest results indicate a challenging financial situation. In Q3 FY26, the company reported net sales of ₹6.75 crores, which represents a slight quarter-on-quarter increase of 3.21%. However, this is concerning as it reflects a significant year-on-year decline of 29.69% from ₹9.60 crores in Q3 FY25.<BR><BR>More troubling is the company's continued operating losses, with an operating profit before depreciation, interest, tax, and other income (PBDIT) of -₹0.41 crores, resulting in an operating margin of -6.07%. This marks the third consecutive quarter of net losses, with a reported net loss of ₹0.55 crores, deepening from previous losses.<BR><BR>The financial performance highlights persistent operational challenges, including a dramatic decline in revenue and negative return metrics, with a return on equity (ROE) of -3.43% and return on capital employed (ROCE) of -2.31%. The absence of institutional investors and a micro-cap classification further complicate the company's outlook.<BR><BR>Overall, the results suggest that Sreechem Resins is currently in a difficult position, facing significant operational inefficiencies and declining market performance.

View full answer

How has been the historical performance of Sreechem Resins?

13-Nov-2025

Sreechem Resins has experienced significant financial declines, with net sales and operating income dropping from INR 76.53 crore in March 2023 to INR 35.50 crore in March 2025, resulting in negative profits and a loss of INR 0.30 crore in March 2025. Despite improved cash flow from operations, the company has struggled with sales and profitability over the years.

Answer:<BR>The historical performance of Sreechem Resins shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Sreechem Resins experienced a decline in net sales from INR 76.53 crore in March 2023 to INR 35.50 crore in March 2025. This downward trend is mirrored in total operating income, which also decreased from INR 76.53 crore in March 2023 to INR 35.50 crore in March 2025. The raw material cost followed a similar pattern, dropping from INR 58.54 crore in March 2023 to INR 26.23 crore in March 2025. Operating profit (PBDIT) saw a significant decline, falling from INR 4.16 crore in March 2024 to INR 0.33 crore in March 2025, leading to a negative profit before tax of INR 0.52 crore in March 2025, compared to a profit of INR 3.21 crore in March 2024. Consequently, profit after tax also turned negative, recording a loss of INR 0.30 crore in March 2025, down from a profit of INR 2.34 crore in March 2024. The company's total assets decreased from INR 20.10 crore in March 2024 to INR 17.27 crore in March 2025, while total liabilities also fell from INR 20.10 crore to INR 17.27 crore during the same period. Cash flow from operating activities improved to INR 3.00 crore in March 2025, compared to no cash flow in March 2024, although cash flow from investing and financing activities remained negative. Overall, Sreechem Resins has faced challenges in maintaining sales and profitability, leading to a notable decline in financial performance over the past few years.

View full answer

Is Sreechem Resins overvalued or undervalued?

09-Jun-2025

As of June 2, 2025, Sreechem Resins is considered overvalued with a negative PE ratio of -17.64, high EV to EBITDA ratio of 19.79, and poor profitability metrics, leading to a year-to-date stock return of -25.07%, significantly underperforming compared to its peers and the Sensex.

As of 2 June 2025, Sreechem Resins has moved from an attractive to a risky valuation grade. The company appears to be overvalued given its negative PE ratio of -17.64 and an EV to EBITDA ratio of 19.79, which is significantly higher than its peers. Additionally, the ROCE and ROE are both negative at -2.31% and -2.03%, respectively, indicating poor profitability and efficiency.<BR><BR>In comparison to its peers, Sreechem Resins stands out unfavorably; for instance, Solar Industries India Ltd. has a PE ratio of 123.77, while Godrej Industries Ltd. shows a PE of 46.63. The disparity in valuation metrics suggests that Sreechem Resins is not only underperforming but also lacks the financial health seen in its competitors. The company's stock has underperformed relative to the Sensex, with a year-to-date return of -25.07% compared to the Sensex's 5.62%, reinforcing the notion that Sreechem Resins is currently overvalued.

View full answer

What is the technical trend for Sreechem Resins?

09-Jun-2025

As of May 26, 2025, Sreechem Resins shows a mildly bearish trend overall, with weekly indicators like the MACD and KST suggesting mild bullishness, while daily moving averages and Bollinger Bands remain bearish.

As of 26 May 2025, the technical trend for Sreechem Resins has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The Bollinger Bands are bearish on both weekly and monthly time frames, and the daily moving averages are also bearish. The KST shows a mildly bullish trend on the weekly but mildly bearish on the monthly. Dow Theory indicates a no trend on the weekly but mildly bullish on the monthly. Overall, the current technical stance is mildly bearish, with key indicators such as the daily moving averages and Bollinger Bands contributing to this outlook.

View full answer

Who are the top shareholders of the Sreechem Resins?

06-Jun-2025

The top shareholders of Sreechem Resins include promoter Satya Narayan Kabra with 10.6% and public shareholder Kasturi Fiscal Pvt. Ltd. with 11.49%. Individual investors hold a significant 50.53% of the shares, with no pledged promoter holdings or mutual funds/foreign institutional investors involved.

The top shareholders of Sreechem Resins include Satya Narayan Kabra, who is the promoter with the highest holding at 10.6%. The highest public shareholder is Kasturi Fiscal Pvt. Ltd., holding 11.49%. Additionally, individual investors collectively hold a significant portion, accounting for 50.53% of the shares. Notably, there are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors holding shares.

View full answer

Has Sreechem Resins declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -167.51% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.84
2

Risky - Negative Operating Profits

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 14 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

42

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.15

stock-summary
Return on Equity

-1.40%

stock-summary
Price to Book

1.00

Revenue and Profits:
Net Sales:
8 Cr
(Quarterly Results - Mar 2026)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
5.0%
0%
5.0%
1 Year
-14.79%
0%
-14.79%
2 Years
-53.14%
0%
-53.14%
3 Years
-27.91%
0%
-27.91%
4 Years
-32.33%
0%
-32.33%
5 Years
22.14%
0%
22.14%

Sreechem Resins for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Jun-2026 | Source : BSE

In terms of Regulation 47(3) Company had published their Audited Financial Results for the Quarter and Year ended March 31 2026 in newspapers.

Standalone Audited Financial Results For The Quarter And Year Ended March 31 2026 In Compliance With IND AS Rules

29-May-2026 | Source : BSE

Standalone Audited Financial Results for the Quarter and Year ended March 31 2026 in compliance with IND AS Rules as approved by the board in their meeting held today ie. May 29 2026

Board Meeting Outcome for Standalone Audited Financial Results For The Quarter And Year Ended March 31 2026 In Compliance With IND AS Rules

29-May-2026 | Source : BSE

This is to inform you that a meeting of the Board of Directors of our Company was held today May 29 2026 at the corporate office of the Company which approved and took on record the Standalone Audited Financial Results for the Quarter and Year ended March 31 2026. In order to comply with the Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing with this letter Standalone Audited Financial Results for the Quarter and Year ended March 31 2026 as per IND-AS Rules along with the Audit Report issued by the Statutory Auditors and a declaration to the effect that Auditors Report on Standalone Audited Financial Results of the Company is with unmodified opinion.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-2.90%
EBIT Growth (5y)
-167.51%
EBIT to Interest (avg)
1.84
Debt to EBITDA (avg)
1.17
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
3.54
Tax Ratio
33.33%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
15.66%
ROE (avg)
15.53%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
42
Price to Book Value
0.96
EV to EBIT
-15.82
EV to EBITDA
15.82
EV to Capital Employed
0.96
EV to Sales
0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.31%
ROE (Latest)
-1.40%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Satya Narayan Kabra (10.6%)

Highest Public shareholder

Kasturi Fiscal Pvt. Ltd. (11.49%)

Individual Investors Holdings

50.31%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 16.15% vs 3.21% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 290.91% vs 3.51% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.84",
          "val2": "6.75",
          "chgp": "16.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.94",
          "val2": "-0.41",
          "chgp": "329.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.04",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.05",
          "val2": "-0.55",
          "chgp": "290.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.99%",
          "val2": "-6.07%",
          "chgp": "18.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -11.13% vs 10.63% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -40.00% vs 25.37% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.17",
          "val2": "17.07",
          "chgp": "-11.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.36",
          "val2": "-0.13",
          "chgp": "-176.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.14",
          "chgp": "-35.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.70",
          "val2": "-0.50",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.37%",
          "val2": "-0.76%",
          "chgp": "-1.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -17.81% vs -24.06% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -50.60% vs -154.61% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.92",
          "val2": "26.67",
          "chgp": "-17.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.77",
          "val2": "-0.25",
          "chgp": "-208.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.13",
          "val2": "0.23",
          "chgp": "-43.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.25",
          "val2": "-0.83",
          "chgp": "-50.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.51%",
          "val2": "-0.94%",
          "chgp": "-2.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -16.20% vs -32.98% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 23.33% vs -112.82% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.75",
          "val2": "35.50",
          "chgp": "-16.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.16",
          "val2": "0.17",
          "chgp": "-5.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.21",
          "val2": "0.32",
          "chgp": "-34.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.23",
          "val2": "-0.30",
          "chgp": "23.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.54%",
          "val2": "0.48%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
7.84
6.75
16.15%
Operating Profit (PBDIT) excl Other Income
0.94
-0.41
329.27%
Interest
0.08
0.04
100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.05
-0.55
290.91%
Operating Profit Margin (Excl OI)
11.99%
-6.07%
18.06%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 16.15% vs 3.21% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 290.91% vs 3.51% in Dec 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
15.17
17.07
-11.13%
Operating Profit (PBDIT) excl Other Income
-0.36
-0.13
-176.92%
Interest
0.09
0.14
-35.71%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.70
-0.50
-40.00%
Operating Profit Margin (Excl OI)
-2.37%
-0.76%
-1.61%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -11.13% vs 10.63% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -40.00% vs 25.37% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
21.92
26.67
-17.81%
Operating Profit (PBDIT) excl Other Income
-0.77
-0.25
-208.00%
Interest
0.13
0.23
-43.48%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.25
-0.83
-50.60%
Operating Profit Margin (Excl OI)
-3.51%
-0.94%
-2.57%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -17.81% vs -24.06% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -50.60% vs -154.61% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
29.75
35.50
-16.20%
Operating Profit (PBDIT) excl Other Income
0.16
0.17
-5.88%
Interest
0.21
0.32
-34.38%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.23
-0.30
23.33%
Operating Profit Margin (Excl OI)
0.54%
0.48%
0.06%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -16.20% vs -32.98% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 23.33% vs -112.82% in Mar 2025

stock-summaryCompany CV
About Sreechem Resins Ltd. stock-summary
stock-summary
Sreechem Resins Ltd.
Micro Cap
Commodity Chemicals
Sreechem Resins Limited was incorporated on May 16, 1988. The Company is principally engaged in production of Resins at its plant located at Jhagarpur (Rajgangpur) and Raigarh. The Company is a leading manufacturer of Magnesia Carbon Refractory, Alumina Carbon Refractory, Dolomite Refractory, and Continuous Casting Refractory.
Company Coordinates stock-summary
Company Details
Vill Jhagarpur, P B No 13 Post Rajgangpur Sundargarh Orissa : 770017
stock-summary
Tel: 91-06624-211943/211944/211943
stock-summary
sreechem@sreechem.in
Registrar Details
MCS Share Transfer Agent Ltd., Formerly MCS Ltd., 12/1/5, Monoharpukar Road, Kolkata